Is CLBT a good stock to buy? We came across a bullish thesis on Cellebrite DI Ltd. on Danny’s Substack by Danny Green. In this article we will summarize the bulls’ thesis on CLBT. Cellebrite DI Ltd. stock was trading at $13.38 on April 20. CLBT’s trailing and forward P/E were 43.16 and 35.71 respectively, according to Yahoo Finance.
Copyright: welcomia / 123RF Stock Photo
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas and Asia-Pacific. CLBT has established itself as the leading provider of digital forensics and investigation solutions, backed by a unique three-layer moat of proprietary device unlocking technology, two decades of judicial accreditation and fully integrated workflow platforms. Its mobile device extraction tools, connected to 45% of the installed base, require constant research and development to keep pace with security updates from Apple and Google, creating a living technical moat that competitors cannot replicate at scale.
Read more: 15 AI Stocks That Are Quietly Making Investors Rich
Read more: Undervalued AI Stocks Poised for Massive Gains: 10000% Upgrade Potential
Legal and regulatory accreditations further assure institutional clients, as evidence collected with Cellebrite tools is admissible in courts in over 100 countries, resulting in years-long switching costs. The company’s integrated Case-to-Closure platform, which combines device extraction, AI analysis, evidence management and open source intelligence, ensures that switching to competitors is operationally prohibitive, driving subscription-based revenue with net retention of over 120%.
The acquisition of Corellium in 2025 expands Cellebrite’s capabilities into ARM-based devices, IoT, automotive and smart infrastructure, while the acquisition of SCG Canada positions the company in drone forensics, expanding its total addressable market. Structural tailwinds from digitalization, increasing mobile evidence, and expanding law enforcement and enterprise adoption underpin sustained growth, with ARR reaching $481 million in 2025, 85% subscription-based, 34% FCF margins, and a cash-rich balance sheet of $484 million.
Near-term catalysts include the authorization of the FedRAMP cloud in 2026 for US federal agencies and the launch of Guardian Investigate AI analytics, which could accelerate ARR growth and deepen platform lock-in. Risks include federal spending volatility, increased device security, human rights regulatory scrutiny, and Sun Corporation’s excess ownership of approximately 40%.